| Ashley Devonien Rasmussen, LPN | |
|
670 W Fireweed Ln Ste 160, Anchorage, AK 99503-2561 | |
| (907) 770-0862 | |
| Not Available |
| Full Name | Ashley Devonien Rasmussen |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 670 W Fireweed Ln Ste 160, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679131528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 145844 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Devonien Rasmussen, LPN 57266 Juarez Dr, Yucca Valley, CA 92284-9524 Ph: (760) 895-3795 | Ashley Devonien Rasmussen, LPN 670 W Fireweed Ln Ste 160, Anchorage, AK 99503-2561 Ph: (907) 770-0862 |
News Archive
Between 1998 and 2008, heart-failure related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study in the October 19 issue of JAMA. Also, 1-year mortality rates declined slightly during this period, but remain high.
A neuroimaging study suggests that patients with schizophrenia have difficulty deactivating the default mode network, rather than having increased absolute metabolic activity.
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2011.
The World Health Organization (WHO) declared the Zika virus infection a global threat during the peak of its outbreak in 2016. Since then, scientists and health experts raced to understand the virus better to develop novel and effective vaccines and treatments for the disease. Now, a team of researchers in China revealed how a protein in the virus reshapes its host to boost viral replication.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 8 days ago
Ms. Dessie Natillia Cooper, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 711 H St Ste 100, Anchorage, AK 99501 Phone: 907-770-0862 | |
Cynthia Kelly, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Eteva Tautu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6916 Windsor Pl, Anchorage, AK 99502 Phone: 907-885-7624 | |
Nicholas Morley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 121 W Fireweed Ln Ste 105, Anchorage, AK 99503 Phone: 907-865-9653 Fax: 907-865-9124 | |
Ms. Susie Ann Edwards, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 | |
Stephanie Louise Melendez, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Naomi Caskey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 |